{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:28:13Z","timestamp":1792740493985,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012149","name":"National Key Scientific Instrument and Equipment Development Projects of China","doi-asserted-by":"crossref","award":["2018YFC1005003"],"award-info":[{"award-number":["2018YFC1005003"]}],"id":[{"id":"10.13039\/501100012149","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Traditionally, final follicular maturation is triggered by a single bolus of human chorionic gonadotropin (hCG). This acts as a surrogate to the naturally occurring luteinizing hormone (LH) surge to induce luteinization of the granulosa cells, resumption of meiosis and final oocyte maturation. More recently, a bolus of gonadotropin-releasing hormone (GnRH) agonist in combination with hCG (dual trigger) has been suggested as an alternative regimen to achieve final follicular maturation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study was a systematic review and meta-analysis of randomized trials evaluating the effect of dual trigger versus hCG trigger for follicular maturation on pregnancy outcomes in women undergoing in vitro fertilization (IVF). The primary outcome was the live birth rate (LBR) per started cycle.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 1048 participants were included in the analysis, with 519 in the dual trigger group and 529 in the hCG trigger group. Dual trigger treatment was associated with a significantly higher LBR per started cycle compared with the hCG trigger treatment (risk ratio (RR)\u2009=\u20091.37 [1.07, 1.76], I<jats:sup>2<\/jats:sup>\u00a0=\u20090%, moderate evidence). There was a trend towards an increase in both ongoing pregnancy rate (RR\u2009=\u20091.34 [0.96, 1.89], I<jats:sup>2<\/jats:sup>\u00a0=\u20090%, low evidence) and implantation rate (RR\u2009=\u20091.31 [0.90, 1.91], I<jats:sup>2<\/jats:sup>\u00a0=\u200976%, low evidence) with dual trigger treatment compared with hCG trigger treatment. Dual trigger treatment was associated with a significant increase in clinical pregnancy rate (RR\u2009=\u20091.29 [1.10, 1.52], I<jats:sup>2<\/jats:sup>\u00a0=\u200913%, low evidence), number of oocytes collected (mean difference (MD)\u2009=\u20091.52 [0.59, 2.46), I<jats:sup>2<\/jats:sup>\u00a0=\u200953%, low evidence), number of mature oocytes collected (MD\u2009=\u20091.01 [0.43, 1.58], I<jats:sup>2<\/jats:sup>\u00a0=\u200918%, low evidence), number of fertilized oocytes (MD\u2009=\u20090.73 [0.16, 1.30], I<jats:sup>2<\/jats:sup>\u00a0=\u20097%, low evidence) and significantly more usable embryos (MD\u2009=\u20090.90 [0.42, 1.38], I<jats:sup>2<\/jats:sup>\u00a0=\u20090%, low evidence).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Dual trigger treatment with GnRH agonist and HCG is associated with an increased live birth rate compared with conventional hCG trigger.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.php?RecordID=204452\">CRD42020204452<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12958-021-00766-5","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T04:01:08Z","timestamp":1622520068000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["GnRH agonist and hCG (dual trigger) versus hCG trigger for follicular maturation: a systematic review and meta-analysis of randomized trials"],"prefix":"10.1186","volume":"19","author":[{"given":"Kai-Lun","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,1]]},"reference":[{"issue":"5","key":"766_CR1","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.fertnstert.2012.11.037","volume":"99","author":"ME Thoma","year":"2013","unstructured":"Thoma ME, McLain AC, Louis JF, King RB, Trumble AC, Sundaram R, et al. Prevalence of infertility in the United States as estimated by the current duration approach and a traditional constructed approach. Fertil Steril. 2013;99(5):1324\u201331.e1.","journal-title":"Fertil Steril"},{"issue":"4","key":"766_CR2","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/1471-0528.14966","volume":"125","author":"Z Zhou","year":"2018","unstructured":"Zhou Z, Zheng D, Wu H, Li R, Xu S, Kang Y, et al. Epidemiology of infertility in China: a population-based study. BJOG. 2018;125(4):432\u201341. https:\/\/doi.org\/10.1111\/1471-0528.14966.","journal-title":"BJOG"},{"issue":"5","key":"766_CR3","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/S0015-0282(03)00173-0","volume":"79","author":"M Ludwig","year":"2003","unstructured":"Ludwig M, Doody KJ, Doody KM. Use of recombinant human chorionic gonadotropin in ovulation induction. Fertil Steril. 2003;79(5):1051\u20139. https:\/\/doi.org\/10.1016\/S0015-0282(03)00173-0.","journal-title":"Fertil Steril"},{"issue":"1","key":"766_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13048-015-0187-6","volume":"8","author":"R Orvieto","year":"2015","unstructured":"Orvieto R. Triggering final follicular maturation--hCG, GnRH-agonist or both, when and to whom? J Ovarian Res. 2015;8(1):60. https:\/\/doi.org\/10.1186\/s13048-015-0187-6.","journal-title":"J Ovarian Res"},{"issue":"4","key":"766_CR5","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1210\/jcem-71-4-918","volume":"71","author":"Y Gonen","year":"1990","unstructured":"Gonen Y, Balakier H, Powell W, Casper RF. Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization. J Clin Endocrinol Metab. 1990;71(4):918\u201322. https:\/\/doi.org\/10.1210\/jcem-71-4-918.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"766_CR6","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1093\/humrep\/deh765","volume":"20","author":"P Humaidan","year":"2005","unstructured":"Humaidan P, Bredkjaer HE, Bungum L, Bungum M, Gr\u00f8ndahl ML, Westergaard L, et al. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: a prospective randomized study. Hum Reprod. 2005;20(5):1213\u201320. https:\/\/doi.org\/10.1093\/humrep\/deh765.","journal-title":"Hum Reprod"},{"issue":"1","key":"766_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.fertnstert.2007.06.030","volume":"90","author":"BS Shapiro","year":"2008","unstructured":"Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Thomas S. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization. Fertil Steril. 2008;90(1):231\u20133. https:\/\/doi.org\/10.1016\/j.fertnstert.2007.06.030.","journal-title":"Fertil Steril"},{"issue":"10","key":"766_CR8","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1093\/humrep\/dep246","volume":"24","author":"P Humaidan","year":"2009","unstructured":"Humaidan P, Papanikolaou EG, Tarlatzis BC. GnRHa to trigger final oocyte maturation: a time to reconsider. Hum Reprod. 2009;24(10):2389\u201394. https:\/\/doi.org\/10.1093\/humrep\/dep246.","journal-title":"Hum Reprod"},{"issue":"1","key":"766_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12958-018-0451-x","volume":"17","author":"MH Lin","year":"2019","unstructured":"Lin MH, Wu FS, Hwu YM, Lee RK, Li RS, Li SH. Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin significantly improves live birth rate for women with diminished ovarian reserve. Reprod Biol Endocrinol. 2019;17(1):7. https:\/\/doi.org\/10.1186\/s12958-018-0451-x.","journal-title":"Reprod Biol Endocrinol"},{"issue":"5","key":"766_CR10","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.fertnstert.2013.07.1976","volume":"100","author":"MH Lin","year":"2013","unstructured":"Lin MH, Wu FS, Lee RK, Li SH, Lin SY, Hwu YM. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles. Fertil Steril. 2013;100(5):1296\u2013302. https:\/\/doi.org\/10.1016\/j.fertnstert.2013.07.1976.","journal-title":"Fertil Steril"},{"issue":"7","key":"766_CR11","doi-asserted-by":"publisher","first-page":"e0235707","DOI":"10.1371\/journal.pone.0235707","volume":"15","author":"CU Chern","year":"2020","unstructured":"Chern CU, Li JY, Tsui KH, Wang PH, Wen ZH, Lin LT. Dual-trigger improves the outcomes of in vitro fertilization cycles in older patients with diminished ovarian reserve: a retrospective cohort study. PLoS One. 2020;15(7):e0235707. https:\/\/doi.org\/10.1371\/journal.pone.0235707.","journal-title":"PLoS One"},{"issue":"6","key":"766_CR12","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.fertnstert.2012.03.015","volume":"97","author":"D Griffin","year":"2012","unstructured":"Griffin D, Benadiva C, Kummer N, Budinetz T, Nulsen J, Engmann L. Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders. Fertil Steril. 2012;97(6):1316\u201320. https:\/\/doi.org\/10.1016\/j.fertnstert.2012.03.015.","journal-title":"Fertil Steril"},{"issue":"5","key":"766_CR13","doi-asserted-by":"publisher","first-page":"101728","DOI":"10.1016\/j.jogoh.2020.101728","volume":"49","author":"SS Ali","year":"2020","unstructured":"Ali SS, Elsenosy E, Sayed GH, Farghaly TA, Youssef AA, Badran E, et al. Dual trigger using recombinant HCG and gonadotropin-releasing hormone agonist improve oocyte maturity and embryo grading for normal responders in GnRH antagonist cycles: randomized controlled trial. J Gynecol Obstet Hum Reprod. 2020;49(5):101728. https:\/\/doi.org\/10.1016\/j.jogoh.2020.101728.","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"7","key":"766_CR14","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1093\/humrep\/deaa107","volume":"35","author":"J Haas","year":"2020","unstructured":"Haas J, Bassil R, Samara N, Zilberberg E, Mehta C, Orvieto R, et al. GnRH agonist and hCG (dual trigger) versus hCG trigger for final follicular maturation: a double-blinded, randomized controlled study. Hum Reprod. 2020;35(7):1648\u201354. https:\/\/doi.org\/10.1093\/humrep\/deaa107.","journal-title":"Hum Reprod"},{"issue":"1","key":"766_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00404-018-4751-3","volume":"298","author":"CH Chen","year":"2018","unstructured":"Chen CH, Tzeng CR, Wang PH, Liu WM, Chang HY, Chen HH, et al. Dual triggering with GnRH agonist plus hCG versus triggering with hCG alone for IVF\/ICSI outcome in GnRH antagonist cycles: a systematic review and meta-analysis. Arch Gynecol Obstet. 2018;298(1):17\u201326. https:\/\/doi.org\/10.1007\/s00404-018-4751-3.","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"766_CR16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction\u2014GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.026.","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"766_CR17","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1093\/humrep\/dex234","volume":"32","author":"F Zegers-Hochschild","year":"2017","unstructured":"Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R, et al. The international glossary on infertility and fertility care, 2017. Hum Reprod. 2017;32(9):1786\u2013801. https:\/\/doi.org\/10.1093\/humrep\/dex234.","journal-title":"Hum Reprod"},{"issue":"3","key":"766_CR18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.fertnstert.2017.06.005","volume":"108","author":"F Zegers-Hochschild","year":"2017","unstructured":"Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R, et al. The international glossary on infertility and fertility care, 2017. Fertil Steril. 2017;108(3):393\u2013406. https:\/\/doi.org\/10.1016\/j.fertnstert.2017.06.005.","journal-title":"Fertil Steril"},{"issue":"7","key":"766_CR19","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1080\/09513590.2019.1576621","volume":"35","author":"J Haas","year":"2019","unstructured":"Haas J, Zilberberg E, Nahum R, Mor Sason A, Hourvitz A, Gat I, et al. Does double trigger (GnRH-agonist\u2009+\u2009hCG) improve outcome in poor responders undergoing IVF-ET cycle? A pilot study. Gynecol Endocrinol. 2019;35(7):628\u201330. https:\/\/doi.org\/10.1080\/09513590.2019.1576621.","journal-title":"Gynecol Endocrinol"},{"issue":"7","key":"766_CR20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.29252\/ijrm.15.7.429","volume":"15","author":"M Eftekhar","year":"2017","unstructured":"Eftekhar M, Mojtahedi MF, Miraj S, Omid M. Final follicular maturation by administration of GnRH agonist plus HCG versus HCG in normal responders in ART cycles: An RCT. Int J Reprod Biomed. 2017;15(7):429\u201334.","journal-title":"Int J Reprod Biomed"},{"issue":"2","key":"766_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4103\/0974-1208.183506","volume":"9","author":"N Mahajan","year":"2016","unstructured":"Mahajan N, Sharma S, Arora PR, Gupta S, Rani K, Naidu P. Evaluation of dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin in improving oocyte maturity rates: a prospective randomized study. J Hum Reprod Sci. 2016;9(2):101\u20136. https:\/\/doi.org\/10.4103\/0974-1208.183506.","journal-title":"J Hum Reprod Sci"},{"issue":"1\u20132","key":"766_CR22","first-page":"63","volume":"59","author":"CH Kim","year":"2014","unstructured":"Kim CH, Ahn JW, You RM, Kim SH, Chae HD, Kang BM. Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization. J Reprod Med. 2014;59(1\u20132):63\u20138.","journal-title":"J Reprod Med"},{"issue":"4","key":"766_CR23","first-page":"203","volume":"6","author":"W Decleer","year":"2014","unstructured":"Decleer W, Osmanagaoglu K, Seynhave B, Kolibianakis S, Tarlatzis B, Devroey P. Comparison of hCG triggering versus hCG in combination with a GnRH agonist: a prospective randomized controlled trial. Facts Views Vision ObGyn. 2014;6(4):203\u20139.","journal-title":"Facts Views Vision ObGyn"},{"issue":"4","key":"766_CR24","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.fertnstert.2007.07.1316","volume":"90","author":"M Schachter","year":"2008","unstructured":"Schachter M, Friedler S, Ron-El R, Zimmerman AL, Strassburger D, Bern O, et al. Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study. Fertil Steril. 2008;90(4):1087\u201393. https:\/\/doi.org\/10.1016\/j.fertnstert.2007.07.1316.","journal-title":"Fertil Steril"},{"key":"766_CR25","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3389\/fendo.2018.00545","volume":"9","author":"S Fernando","year":"2018","unstructured":"Fernando S, Wallace EM, Vollenhoven B, Lolatgis N, Hope N, Wong M, et al. Melatonin in assisted reproductive technology: a pilot double-blind randomized placebo-controlled clinical trial. Front Endocrinol. 2018;9:545. https:\/\/doi.org\/10.3389\/fendo.2018.00545.","journal-title":"Front Endocrinol"},{"issue":"3","key":"766_CR26","doi-asserted-by":"publisher","first-page":"225","DOI":"10.22074\/ijfs.2019.5717","volume":"13","author":"F Mokhtari","year":"2019","unstructured":"Mokhtari F, Akbari Asbagh F, Azmoodeh O, Bakhtiyari M, Almasi-Hashiani A. Effects of melatonin administration on chemical pregnancy rates of polycystic ovary syndrome patients undergoing intrauterine insemination: a randomized clinical trial. Int J Fertil Steril. 2019;13(3):225\u20139. https:\/\/doi.org\/10.22074\/ijfs.2019.5717.","journal-title":"Int J Fertil Steril"},{"issue":"1","key":"766_CR27","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/humupd\/dmz037","volume":"26","author":"Y Mizrachi","year":"2020","unstructured":"Mizrachi Y, Horowitz E, Farhi J, Raziel A, Weissman A. Ovarian stimulation for freeze-all IVF cycles: a systematic review. Hum Reprod Update. 2020;26(1):118\u201335. https:\/\/doi.org\/10.1093\/humupd\/dmz037.","journal-title":"Hum Reprod Update"},{"issue":"2","key":"766_CR28","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1210\/jcem.87.2.8197","volume":"87","author":"BC Fauser","year":"2002","unstructured":"Fauser BC, de Jong D, Olivennes F, Wramsby H, Tay C, Itskovitz-Eldor J, et al. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. J Clin Endocrinol Metab. 2002;87(2):709\u201315. https:\/\/doi.org\/10.1210\/jcem.87.2.8197.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"766_CR29","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1210\/endo.140.8.6899","volume":"140","author":"F Raga","year":"1999","unstructured":"Raga F, Casa\u00f1 EM, Kruessel J, Wen Y, Bonilla-Musoles F, Polan ML. The role of gonadotropin-releasing hormone in murine preimplantation embryonic development. Endocrinology. 1999;140(8):3705\u201312. https:\/\/doi.org\/10.1210\/endo.140.8.6899.","journal-title":"Endocrinology"},{"issue":"10","key":"766_CR30","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1093\/humrep\/del173","volume":"21","author":"J Tesarik","year":"2006","unstructured":"Tesarik J, Hazout A, Mendoza-Tesarik R, Mendoza N, Mendoza C. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles. Hum Reprod. 2006;21(10):2572\u20139. https:\/\/doi.org\/10.1093\/humrep\/del173.","journal-title":"Hum Reprod"},{"issue":"2","key":"766_CR31","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.fertnstert.2014.04.028","volume":"102","author":"D Griffin","year":"2014","unstructured":"Griffin D, Feinn R, Engmann L, Nulsen J, Budinetz T, Benadiva C. Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates. Fertil Steril. 2014;102(2):405\u20139. https:\/\/doi.org\/10.1016\/j.fertnstert.2014.04.028.","journal-title":"Fertil Steril"},{"issue":"1","key":"766_CR32","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.fertnstert.2007.02.002","volume":"89","author":"L Engmann","year":"2008","unstructured":"Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil Steril. 2008;89(1):84\u201391. https:\/\/doi.org\/10.1016\/j.fertnstert.2007.02.002.","journal-title":"Fertil Steril"},{"issue":"4","key":"766_CR33","doi-asserted-by":"publisher","first-page":"5337","DOI":"10.18632\/oncotarget.23916","volume":"9","author":"S Li","year":"2018","unstructured":"Li S, Zhou D, Yin T, Xu W, Xie Q, Cheng D, et al. Dual trigger of triptorelin and HCG optimizes clinical outcome for high ovarian responder in GnRH-antagonist protocols. Oncotarget. 2018;9(4):5337\u201343. https:\/\/doi.org\/10.18632\/oncotarget.23916.","journal-title":"Oncotarget"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-021-00766-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-021-00766-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-021-00766-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T06:33:42Z","timestamp":1672295622000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-021-00766-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["766"],"URL":"https:\/\/doi.org\/10.1186\/s12958-021-00766-5","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,1]]},"assertion":[{"value":"25 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors approved the final version of the manuscript and consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}